Start |  Archive |  Services |  About Us |  Contact

Search News

Successor to Vioxx fails to quell concerns

When drug company Merck revealed the the results of a study this week over it's successor to Vioxx, the new arthritis drug Arcoxia, it did little to quell concerns about both the use and the safety of the new drug.

Continue to Successor to Vioxx fails to quell concerns on News-Medical News Feed.

Your health is news!

Medical buzz is a member of the HarWester Network.